We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGT icon
126
Vanguard Information Technology ETF
VGT
$147B
$174M 0.15%
3,335,648
-258,512
-7% -$13.3M
MDY icon
127
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$174M 0.15%
353,819
-67,868
-16% -$33M
GLD icon
128
SPDR Gold Trust
GLD
$143B
$170M 0.14%
943,098
+148,058
+19% +$26M
MDLZ icon
129
Mondelez International
MDLZ
$78.5B
$170M 0.14%
2,705,138
-57,442
-2% -$3.74M
NXPI icon
130
NXP Semiconductors
NXPI
$58.9B
$170M 0.14%
916,261
+14,658
+2% +$2.89M
IVW icon
131
iShares S&P 500 Growth ETF
IVW
$77.4B
$170M 0.14%
2,219,971
-162,726
-7% -$12.2M
GSLC icon
132
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16B
$169M 0.14%
1,896,926
-215,242
-10% -$19M
IQV icon
133
IQVIA
IQV
$39.8B
$169M 0.14%
729,957
+28,899
+4% +$6.84M
TSM icon
134
TSMC
TSM
$2.17T
$168M 0.14%
1,613,662
-86,706
-5% -$10.1M
EL icon
135
Estee Lauder
EL
$31.5B
$167M 0.14%
612,719
+34,363
+6% +$10.3M
TJX icon
136
TJX Companies
TJX
$175B
$166M 0.14%
2,741,727
-46,808
-2% -$3.13M
DUK icon
137
Duke Energy
DUK
$94.5B
$162M 0.14%
1,448,141
+36,531
+3% +$3.79M
BLK icon
138
Blackrock
BLK
$175B
$161M 0.14%
211,130
+10,533
+5% +$8.23M
COP icon
139
ConocoPhillips
COP
$148B
$161M 0.14%
1,607,969
+199,454
+14% +$18.3M
ZTS icon
140
Zoetis
ZTS
$30.9B
$159M 0.13%
844,436
-45,732
-5% -$9.04M
SO icon
141
Southern Company
SO
$105B
$159M 0.13%
2,195,334
+1,002
+0% +$67.9K
ENB icon
142
Enbridge
ENB
$112B
$159M 0.13%
3,452,379
+245,238
+8% +$10.5M
LMT icon
143
Lockheed Martin
LMT
$139B
$158M 0.13%
357,693
-107,870
-23% -$43.7M
LOW icon
144
Lowe's Companies
LOW
$123B
$158M 0.13%
780,460
-2,969
-0.4% -$683K
AZN icon
145
AstraZeneca
AZN
$251B
$155M 0.13%
1,171,431
+102,988
+10% +$12.4M
IEUR icon
146
iShares Core MSCI Europe ETF
IEUR
$9.14B
$155M 0.13%
2,904,372
+310,351
+12% +$17M
GILD icon
147
Gilead Sciences
GILD
$165B
$155M 0.13%
2,606,110
+105,652
+4% +$6.75M
FISV
148
Fiserv Inc
FISV
$27.8B
$154M 0.13%
1,521,083
+121,860
+9% +$12.3M
WM icon
149
Waste Management
WM
$90.6B
$154M 0.13%
969,511
-19,396
-2% -$2.94M
TT icon
150
Trane Technologies
TT
$105B
$153M 0.13%
1,003,238
-1,151
-0.1% -$188K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.